PT  - JOURNAL ARTICLE
ED  - ,
TI  - Ulipristal acetate (Esmya): restrictions on use
AID  - 10.1136/dtb.2018.11.000033
DP  - 2018 Nov 01
TA  - Drug and Therapeutics Bulletin
PG  - 127--127
VI  - 56
IP  - 11
4099  - http://dtb.bmj.com/content/56/11/127.short
4100  - http://dtb.bmj.com/content/56/11/127.full
SO  - Drug Ther Bull2018 Nov 01; 56
AB  - Safety alert: Esmya (ulipristal acetate) for symptoms of uterine fibroids: restrictions to use and requirement to check liver function before, during and after treatment.1,2